Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03456453 · ClinicalTrials.gov registry record · NA

Social Media HIV Prevention Intervention for High Risk Rural Women

A NA study, sponsored by Michele Staton.

Completed
Registry status
NA
Development phase
60
Enrollment target

NCT03456453: Completed NA study, sponsored by Michele Staton.

NCT03456453 is a NA study that has completed, run by Michele Staton. The registered enrollment target is 60 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03456453, a NA study, has completed, sponsored by Michele Staton.

COMPLETED
Registry status
NA
Development phase
60 participants
Enrollment target

Study Summary

The overall aim of this R34 application is to adapt and feasibility test an evidence-based HIV prevention education for high-risk, underserved rural women in Appalachia. This study has potential to make a significant contribution to science by advancing knowledge on the use of social media to increase access to prevention interventions to reduce high-risk substance use and related health disparities among rural women during a time of emerging and significant public health risk in Appalachia. Successfully accomplishing study aims will respond to a critical and unmet need to increase access to prevention interventions using social media, as well as advance knowledge about the high-risk drug use behaviors among vulnerable populations.

Primary Outcome

The number of participants who are released and accept the "friend" request from the Facebook study profile

Interventions

  • BEHAVIORAL NIDA Standard for HIV Prevention

Trial Details

FieldValue
Enrollment Target 60 participants
Start Date 2019-05-29
Est. Completion 2022-04-26
Phase NA
Michele Staton

5 total trials

What the finished NCT03456453 record still lists

NCT03456453 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 60 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower).

The record links to 0 conditions, and to 1 intervention - of which NIDA Standard for HIV Prevention is the first listed.

NCT03456453 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT03456453 about?

NCT03456453 is a clinical study titled "Social Media HIV Prevention Intervention for High Risk Rural Women". The overall aim of this R34 application is to adapt and feasibility test an evidence-based HIV prevention education for high-risk, underserved rural women in Appalachia. This study has potential to make a significant contribution to science by advancing knowledge on the use of social media to increa...

What is the current status of trial NCT03456453?

This trial is currently completed. It is a NA study. The enrollment target is 60 participants. The study started on 2019-05-29. Estimated completion is 2022-04-26.

What interventions are being tested in trial NCT03456453?

The interventions under investigation include: NIDA Standard for HIV Prevention (BEHAVIORAL).

Who is sponsoring clinical trial NCT03456453?

This trial is sponsored by Michele Staton, which has 5 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT03456453's enrollment target sits among peer trials

60 1164th of 2000 higher than 745 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00576069 · 60 participants

    Mechanism(s)of Airflow Limitation in Moderate-severe Persistent Asthma

  • NCT01297400 · 60 participants · Phase 2

    Phase 2 Pilot Study of the Safety and Efficacy of Topical MW-III in Thermal Burns

  • NCT01734122 · 60 participants

    Stereotactic Radiosurgery for Essential Tremor and Parkinsonian Tremor

  • NCT01804634 · 60 participants · Phase 2

    Reduced Intensity Haploidentical BMT for High Risk Solid Tumors

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT03456453, the US trial registry maintained by the National Library of Medicine. NCT03456453 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.